Bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells
Authors:
- Marceline CôtéMCMarceline Côté
- Denis LaneDLDenis Lane
- Sylvain L'EspéranceSLSylvain L'Espérance
- Claudine RancourtCRClaudine Rancourt
- Alain PichéAlain Piché
- 30 June 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (3) , 796-806
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- BCL-xL and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinasesOncogene, 2002
- Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562Cancer Gene Therapy, 2000
- Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse modelOncogene, 1999
- Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instabilityOncogene, 1999
- Phenotypic knock-out of the latent membrane protein 1 of Epstein–Barr virus by an intracellular single-chain antibodyGene Therapy, 1998
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Evidence for α-Helical Conformation of an Essential N-terminal Region in the Human Bcl2 ProteinJournal of Biological Chemistry, 1996
- Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death.Journal of Experimental Medicine, 1996
- The protein bcl-2 alpha does not require membrane attachment, but two conserved domains to suppress apoptosis.Journal of Cell Biology, 1994
- Cooperative interaction between c-myc and bcl-2 proto-oncogenesNature, 1992